Invention Grant
- Patent Title: Glycosidase inhibitors
-
Application No.: US16078159Application Date: 2017-02-24
-
Publication No.: US11612599B2Publication Date: 2023-03-28
- Inventor: Anna Quattropani , Santosh S. Kulkarni , Awadut Gajendra Giri
- Applicant: Asceneuron SA
- Applicant Address: CH Lausanne
- Assignee: Asceneuron SA
- Current Assignee: Asceneuron SA
- Current Assignee Address: CH Lausanne
- Agency: Cooley LLP
- Priority: IN201621006636 20160225
- International Application: PCT/EP2017/054268 WO 20170224
- International Announcement: WO2017/144633 WO 20170831
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/496 ; A61K31/454 ; A61K31/498 ; A61K31/4985 ; A61K31/501 ; A61K31/506 ; A61K31/5383 ; C07D401/14 ; C07D403/12 ; C07D405/12 ; C07D405/14 ; C07D413/14 ; C07D417/12 ; C07D417/14 ; C07D471/04 ; C07D487/04 ; C07D491/048 ; C07D491/052 ; C07D495/04 ; C07D498/04 ; C07D513/04 ; C07D519/00
Abstract:
Compounds of formula (I), wherein A, R, W, Q, n and m have the meaning according to the claims, can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
Public/Granted literature
- US20210186958A1 GLYCOSIDASE INHIBITORS Public/Granted day:2021-06-24
Information query
IPC分类:
